Related Experiment Videos
The beta 2-adrenergic agonist terbutaline suppresses experimental allergic neuritis in Lewis rats
D H Kim1, S Muthyala, B Soliven
1Department of Neurology, University of Chicago, IL 60637.
Journal of Neuroimmunology
|May 1, 1994
Abstract:
Treatment of rats with experimental allergic neuritis with the beta 2-adrenergic agonist terbutaline suppresses clinical symptoms, decreases demyelination and Wallerian degeneration in peripheral nerves and improves electrophysiological parameters. Treatment is highly effective when given from the time of immunization through the acute phase of illness, when given for the first 12 days after immunization and also when given after the onset of the disease.